Rx spending out of the spotlight?
Prescription drugs dropped to third place among spending categories driving overall health care cost increases in 2001, a Sept. 25 analysis by the Center for Studying Health System Change shows. Hospital cost increases (particularly for outpatient services) and payment for physician services outpaced Rx spending as a growth driver. Hospital costs represented more than half the overall increase in health care spending in 2001; physician services accounted for 28%. Rx costs accounted for 21% of the increase, down from 34% two years ago...
You may also be interested in...
A “structured dialog” led by the European Commission with pharmaceutical industry stakeholders provides a critical opportunity to address weaknesses in the stability and security of the supply chain by improving the environment for local manufacturing, Medicines for Europe believes.
Despite a slight increase in revenue, South Africa’s Adcock continues to struggle as it reports a continued drop in gross profit. The company expects the economy to remained constrained due to COVID-19, but is eagerly anticipating recovery with the government’s vaccine roll-out.
Round-up of the latest news across EMEA, including two deals for Bayer in Egypt and Saudi Arabia; Orkla's acquisition of NutraQ; and Uriach's deal for Sidroga.